---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/37165911.md"
description: "The biopharmaceutical sector is truly a battlefield. BDRX and RADX have been soaring like a roller coaster recently, with RADX's +100% daily gain even putting the A-shares to shame. Honestly, I'm even afraid to chase the highs...Small-cap pharma stocks are like this—when policy or trial news hits, the drama starts immediately. Unfortunately, my old bones can't take the risk anymore 😮‍💨The volatility in OSCR and YCBD seems like just thematic rotation and hype, but the moat is ultimately too narrow. All I can say is, in this market, what you don't earn is what you keep."
datetime: "2025-12-16T08:03:43.000Z"
locales:
  - [en](https://longbridge.com/en/topics/37165911.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/37165911.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/37165911.md)
author: "[大秦阳泉君](https://longbridge.com/en/profiles/7200473.md)"
generator: "portal-rs"
---

# The biopharmaceutical sector is truly a battlefiel…


### Related Stocks

- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [RADX.US](https://longbridge.com/en/quote/RADX.US.md)
- [OSCR.US](https://longbridge.com/en/quote/OSCR.US.md)
- [YCBD.US](https://longbridge.com/en/quote/YCBD.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**